<DOC>
	<DOCNO>NCT01729676</DOCNO>
	<brief_summary>French epidemiological data show heterogeneous distribution risk mortality prostate cancer accord region . The main objective describe distribution prostate cancer stage first line hormonal therapy introduce ( overall region ) .</brief_summary>
	<brief_title>Impact Geographical FACTor Prostate Cancer Stage Hormonal Therapy Initiation</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Patients histologically demonstrate prostatic adenocarcinoma . Patients never previously treat hormonal therapy prostate cancer . Patients eligible hormonal therapy initial consultation ( alone combination curative treatment ) . Patients agree collection personal health data purpose study . Patients locally advance metastatic prostatic cancer tumours biological recurrence curative treatment . Patients participate clinical study involve prostate cancer time inclusion investigation . Patients receive currently receive hormonal treatment prostate cancer ( surgical castration hormonal manipulation , include GnRH receptor antagonist , antiandrogens , oestrogen , 5 alpha reductase inhibitor ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>